| 000 | 01449 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516112717.0 | ||
| 264 | 0 | _c20131031 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1651-226X | ||
| 024 | 7 |
_a10.3109/0284186X.2012.716165 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBattley, Jodie E | |
| 245 | 0 | 0 |
_aTreatment of BRAF inhibitor-induced hyperkeratosis. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _cMay 2013 |
||
| 300 |
_a874-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aClobetasol _xtherapeutic use |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadverse effects |
| 650 | 0 | 4 |
_aKeratoderma, Palmoplantar _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aOximes _xadverse effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors |
| 700 | 1 | _aLenihan, Elizabeth | |
| 700 | 1 | _aRedmond, Henry P | |
| 700 | 1 | _aMurphy, Michelle | |
| 700 | 1 | _aPower, Derek G | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 52 _gno. 4 _gp. 874-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/0284186X.2012.716165 _zAvailable from publisher's website |
| 999 |
_c22123555 _d22123555 |
||